Free Classifieds at USAOnlineClassifieds.com - View Item Content by ID 1853271

USAOnlineClassifieds > Health & Beauty > Health Services > Item ID 1853271

Item ID 1853271 in Category: Health & Beauty - Health Services

Cannot view this item. It could be pending, expired or deleted.
Below item is randomly selected from the same category and may have similar content.

Cipla targets US respiratory market growth; submits Symbicort and another generic inhaler


Cipla, an Indian pharmaceutical firm, is intensifying its efforts to become a leader in the US market for respiratory medications. The company has filed two generic respiratory drug applications with the US FDA, including a generic version of Symbicort, a medication for asthma and COPD with annual sales exceeding $3 billion. This presents a significant market opportunity for Cipla’s respiratory pipeline. Cipla is also developing several peptide-based respiratory products as part of its speciality drug focus in the US.

Cipla’s respiratory products already constitute a major share of its US generics business. Despite recent regulatory challenges, its Albuterol inhalation product continues to maintain market share, demonstrating the strength of Cipla’s position.

The company is making progress in resolving previous US regulatory observations related to its manufacturing facilities for respiratory drug production, which have hindered key drug approvals in the past.

For more details please visit our website - https://www.medhealthinsight.com/new-soundboard-review-pricing-is-not-always-the-only-criteria-2-9/


Related Link: Click here to visit item owner's website (0 hit)

Target State: New York
Target City : New York City
Last Update : Sep 17, 2025 2:46 AM
Number of Views: 6
Item  Owner  : medhealthinsight
Contact Email: (None)
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
USAOnlineClassifieds > Health & Beauty > Health Services > Item ID 1853271
 © 2025 USAOnlineClassifieds.com
2025-09-17 (0.815 sec)